Shopping Cart

Expired activity

Please go to the PowerPak homepage and select a course.

FACULTY

Paul G. Auwaerter, MD, MBA, FIDSA
Clinical Director, Division of Infectious Diseases
Sherrilyn and Ken Fisher Professor of Medicine
Johns Hopkins University School of Medicine

Chief Medical Officer, Point of Care-Information Technology (POC-IT) Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Michael D. Hogue, PharmD, FAPhA, FNAP
Dean and Professor
Loma Linda University
School of Pharmacy
Loma Linda, California

Deanna Bridge Najera, MPAS, MS, PA-C, NCC, DFAAPA, CAQ-Psych
Department of Emergency Medicine
Carroll Hospital
Westminster, Maryland

TrueNorth Wellness Center
Hanover, Pennsylvania

Agricultural Worker Program
Gettysburg, Pennsylvania

FINANCIAL DISCLOSURE

Faculty
Paul G. Auwaerter, MD – Contracted Research: MicroB-Plex; Consulting Fee: Collidion, DiaSorin, Shionogi; Ownership Interest: Johnson and Johnson

Michael D. Hogue, PharmD – Co-PI on Research Grant: Merck and Company, Inc.; Consulting Fee: GlaxoSmithKline, Pfizer, Inc., Sanofi-Aventis

No other faculty members have indicated that they have any financial interests or relationships with a commercial entity whose products or services are relevant to the content of their presentation(s).

The following reviewer Clark Kebodeaux, PharmD, BCACP, has no actual or potential conflict of interest in relation to this program.

Michael Speidel, Medical Logix, LLC AND Jennifer Gregg, PhD, Atlas Medical Writing, LLC hereby state they do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Susanne Batesko, RN, BSN, Robin Carrino, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. We are committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.

ACCREDITATION STATEMENTS

PHARMACY
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN:  0430-0000-19-130-H06-P
Credits: 1.00 (0.10 CEU) for this CE activity

Type of Activity: Knowledge
Media: Internet

Fee Information: There is no fee for this educational activity.

Estimated time to complete activity: 60 minutes

Published

November 26, 2019

Expires

November 30, 2020

TARGET AUDIENCE

This accredited activity has been designated for pharmacists.

HOW TO OBTAIN CREDIT

During the period November 26, 2019 through November 30, 2020, participants must 1) read the educational objectives and faculty disclosures; 2) study the educational activity; and 3) complete the posttest and the evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on 'Submit Posttest' at the bottom of the page. Your posttest will automatically be graded. If you successfully complete the posttest (score of 70% or higher), your Statement of Credit will be made available immediately. Click on View Certificate and print the Statement of Credit for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest.

GOAL

This activity is designed to inform and educate pharmacy professionals about the use of herpes zoster vaccines.

EDUCATIONAL OBJECTIVES

After participating in this activity, the participant will demonstrate the ability to:

1. Explain the risk factors, disease burden, and overall health impact of herpes zoster (shingles).
2. Implement strategies to improve vaccination uptake.
3. Compare efficacy and safety trial data of zoster vaccine, recombinant, adjuvanted (RZV) and zoster vaccine, live, attenuated (ZVL).
4. Apply the current Advisory Committee on Immunization Practices (ACIP) recommendations appropriately in eligible patients.
5. Outline the benefits of using pharmacy-based vaccination and methods to increase their use.

REQUIRED COMPUTER HARDWARE/SOFTWARE

Please ensure the computer system you plan to use meets the following minimum requirements:

• Operating System: Windows 98 or higher & Macintosh 2.2 or higher
• Internet Browser (Mac &/Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
• Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
• Peripherals: Computer speakers or headphones
• Monitor Screen Resolution: 320 x 480 or higher
• Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

Disclosure of Unlabeled Use and Disclaimer:

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC and GlaxoSmithKline. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions, and possible contraindications on dangers in use, (review of any applicable manufacturer's product information) and comparison with recommendations of other authorities.

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsors promote the use of any agent outside of approved labeling. Statements made in this activity have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.

CLINICAL DIALOGUE PROGRAM DESCRIPTION

Clinical Dialogues are video-based activities where pharmacists are presented with a video discussion among three expert clinicians.

This Clinical Dialogue is in the form of a transcript with corresponding slides taken from the original video.